Litecoin gets its first major treasury backer in MEI Pharma’s $100m play

2025/08/05 23:13

MEI Pharma, a clinical-stage biotech firm, just made an unexpected pivot, allocating nine figures to Litecoin as a treasury asset. With GSR advising and Charlie Lee on board, the move signals a growing institutional belief in crypto’s role beyond speculation.

Summary
  • MEI Pharma becomes the first U.S.-listed public company to adopt Litecoin as its primary treasury reserve, acquiring $110.4M in LTC.
  • The strategy was developed with GSR and Litecoin creator Charlie Lee, reflecting a shift toward operational use of crypto in non-fintech sectors.
  • MEI cited Litecoin’s uptime, efficiency, and broad integration as key reasons behind its pivot from cash to crypto reserves.

On August 4, Nasdaq-listed pharmaceutical company MEI Pharma announced the acquisition of 929,548 Litecoin (LTC) tokens at an average price of $107.58, cementing a $110.4 million bet on the cryptocurrency as a primary reserve asset.

The move, executed in partnership with crypto market maker GSR and guided by Litecoin creator Charlie Lee, who joined MEI’s board earlier this year, marks the first instance of a U.S. public company anchoring its treasury strategy in LTC.

Why Litecoin? The calculus behind MEI Pharma’s crypto pivot

According to the press release, MEI Pharma’s pivot to LTC was shaped by three key factors: network resilience, transactional efficiency, and real-world adoption. With over 13 years of uninterrupted uptime, Litecoin remains one of the longest-running blockchains without a major network failure, a reliability record few protocols can match.

Combined with consistently low fees and fast settlement times, it’s a platform that aligns more with treasury stability than speculative hype.

This endorsement carries weight. Lee’s involvement suggests MEI isn’t merely parking funds in crypto but actively integrating Litecoin into its financial operations. The partnership with GSR, a firm specializing in institutional crypto execution, further signals serious intent.

At the same time, MEI emphasized that its treasury initiative does not signal a pivot away from biotech. The company said it remains committed to its drug development pipeline, which includes voruciclib, a CDK9 inhibitor currently in pre-clinical review. Future R&D activities are still underway, and management indicated plans to proceed with investigational research in the months ahead.

Still, the scale of the Litecoin allocation signals more than a side experiment. The move coincides with MEI’s planned corporate identity refresh, hinting at broader ambitions. Per the press release, the rebranding may include participation in Litecoin mining. That would place MEI in a rare category: a public company attempting to bridge two sectors as different as clinical therapeutics and decentralized finance.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

UK’s Smarter Web Company Issues First Bitcoin-Denominated Convertible Bond Worth $21M

UK’s Smarter Web Company Issues First Bitcoin-Denominated Convertible Bond Worth $21M

The Smarter Web Company raised $21 million through the UK’s first Bitcoin-denominated convertible bond from TOBAM. The London-listed technology firm announced Tuesday that the Paris-based asset management company, which has maintained Bitcoin exposure since 2016, fully subscribed to the “Smarter Convert” instrument through three managed funds. The Smarter Web Company ( #SWC $TSWCF $3M8.F) RNS Announcement: Smarter Convert – $21 Million Subscription. The Smarter Web Company is pleased to announce the launch of Smarter Convert, a strategic, interest free capital-raising initiative structured as a convertible bond,… — The Smarter Web Company (@smarterwebuk) August 6, 2025 Unlike traditional convertible bonds, this structure denominates the principal repayment amount in Bitcoin while keeping the conversion share price fixed at £2.05, representing a 5% premium to Monday’s closing price of £1.95 per share. Revolutionary Bond Structure Offers Bitcoin Upside with Downside Protection The convertible bond includes several unique mechanisms designed to protect both issuer and investor interests in volatile market conditions over its 12-month term. After an initial six-month period, Smarter Web can force conversion to equity if shares trade 50% above the conversion price for ten consecutive trading days, effectively capping the company’s Bitcoin exposure risk. Conversely, if bondholders opt against conversion at maturity, the company will repay 98% of the bond’s Bitcoin-adjusted value and retain 2% to offset transaction costs. This Bitcoin denomination means repayment amounts will fluctuate with cryptocurrency prices rising if Bitcoin appreciates and falling if it declines, while conversion terms remain denominated in British pounds. If all bonds convert to equity, approximately 7.7 million new shares would be issued, calculated by dividing the $21 million at current exchange rates by the £2.05 conversion price. TOBAM CEO Yves Choueifaty described the structure as offering “prudent downside protection, premium equity participation, and a Bitcoin-denominated structure that reflects our conviction in Bitcoin as the next cornerstone of trust.” Similarly, Smarter Web CEO Andrew Webley positioned the offering as expanding funding options, stating the deal “marks yet another first for the UK capital markets” and expressing confidence it will “open up a new segment of capital for the Company.” Corporate Bitcoin Financing Evolves Beyond Pure Equity Dilution Models This convertible bond structure is yet a potential evolution in how Bitcoin-focused companies access capital markets, moving beyond the pure equity dilution model popularized by MicroStrategy. The new approach offers a middle path between traditional debt and equity financing, potentially addressing concerns raised by analysts about excessive shareholder dilution in the corporate Bitcoin treasury space. UK BTC Companies Accumulation Race (Source: Smarter Web ) Smarter Web’s aggressive Bitcoin accumulation strategy has generated remarkable returns, with the company achieving a 49,198% year-to-date BTC yield through multiple purchases throughout 2025, including 325 Bitcoin in July and 196.8 Bitcoin in June. 🚀 Smarter Web Company crosses 2,000 Bitcoin mark after $27 million purchase reaching top 25 global corporate rankings with 49,198% YTD yield. #Bitcoin #Treasury https://t.co/cDM2etAMnF — Cryptonews.com (@cryptonews) July 30, 2025 The company has invested £166.8 million total at an average price of £81,346 per coin, positioning itself among the top 25 global corporate Bitcoin holders with approximately £500,000 in remaining treasury cash for future deployments. However, this aggressive strategy has driven significant stock volatility, with shares falling 15% after recent fundraising despite being up 274% year-to-date. Meanwhile, Japanese Bitcoin investment firm Metaplanet recently filed to raise $3.6 billion through preferred stock offerings, demonstrating continued appetite for innovative financing structures in the sector. The broader corporate Bitcoin treasury movement has seen over 283 companies accumulate 3.64 million Bitcoin collectively, though some industry observers question the sustainability of current strategies. In fact, Galaxy Digital’s Michael Novogratz recently suggested the market may have reached “peak treasury company issuance,” shifting focus to which existing players will achieve meaningful scale. Even earlier this year, VanEck’s Matthew Sigel warned that companies issuing shares near their Bitcoin net asset value risk creating “erosion” rather than capital formation.
Share
CryptoNews2025/08/06 22:06